Agilent partners with NUS to advance cardiovascular research in Singapore

The collaboration will span four years.

Agilent Technologies has entered into a strategic partnership with the National University of Singapore (NUS), through NUS Medicine, to establish a Center of Excellence in Cell Metabolism.

The collaboration aims to advance research in cardiovascular and metabolic diseases over the next four years.

Agilent’s integrated metabolic and cellular phenotyping platforms, such as xCELLigence, Seahorse XF, and BioTek technologies enable efficient cell studies. This will facilitate the discovery of new therapeutic targets and cardio-liver-metabolic biomarkers to prevent CVDs.

According to GlobalData, global partnerships are expected to strengthen NUS’ Project RESET, which aims to advance cardiovascular research in the country.

“By developing innovative, preventative healthcare strategies and enhancing local expertise in cardiovascular research, Singapore aims to reduce healthcare costs associated with CVDs. Furthermore, international collaborations will elevate Singapore’s status as a hub for biomedical research, attracting investment, talent, and boosting the local economy over time,” Shreya Jain, Medical Devices Analyst at GlobalData said.

Follow the link for more news on

National University of Singapore

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia